Drug reference
omalizumab
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Respiratory (Monoclonal antibody(Respiratory))
Mechanism of action
Recombinant humanized monoclonal antibody; selectively binds to IgE and inhibits binding to IgE receptors on surface of mast cells and basophils.
Common side effects
- Injection site reactions
- Arthralgia
- Headache
- Pain (Leg Pain)
- Nasopharyngitis.
Contraindications
- Severe hypersensitivity reaction to omalizumab or any of its excipients
Related conditions
Frequently asked questions
What drug class is omalizumab?
omalizumab belongs to: Respiratory.
How does omalizumab work?
Recombinant humanized monoclonal antibody; selectively binds to IgE and inhibits binding to IgE receptors on surface of mast cells and basophils.
What are the common side effects of omalizumab?
Injection site reactions, Arthralgia, Headache, Pain (Leg Pain), Nasopharyngitis.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.